PSI CRO has moved its base of operations in Bulgaria to a new office in Sofia at 1 Atanas Dukov St. Learn more about how we're combining local expertise with on-the-ground support for sponsors and sites. https://bit.ly/3VVKmJ4
PSI CRO AG
Arzneimittelherstellung
The global CRO where clinical trials run on time.
Info
PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines. PSI’s global reach allows us to run clinical trials across multiple continents, in 50+ countries around the world. PSI’s reputation is that of a 'no-nonsense' CRO focused on timely patient enrollment and project delivery. An exceptionally high repeat and referral business rates alongside low staff turnover are indicative of our commitment to be the best CRO in the world as measured by our clients and our employees. http://www.psi-cro.com
- Website
-
http://www.psi-cro.com
Externer Link zu PSI CRO AG
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zug
- Art
- Privatunternehmen
- Gegründet
- 1995
- Spezialgebiete
- Number One Patient Enrollment CRO, Clinical Research, Clinical Trials, Oncology, Hematology, Multiple Sclerosis, Infectious Diseases, Patient Enrollment, Phase 2 , Phase 3, Pivotal Trials, Global Clinical Trials und Full-Service Clinical Trials
Orte
-
Primär
Baarerstrasse 113a
Zug, 6300, CH
Beschäftigte von PSI CRO AG
Updates
-
We believe that our people are our greatest asset. They are the heart and soul of everything we do, driving us toward our mission to be the best CRO in the world as measured by our employees, clients, sites, and vendors. Read our latest blog to explore results from our first annual global engagement survey, reflecting the heartbeat of our diverse team across 60 countries: https://bit.ly/3wD9cni #PSIProud
-
-
Turkey's clinical trial market is expected to grow over the next decade, and PSI is poised to support this expansion with the opening of its first office in Ankara. Learn more here. https://bit.ly/4faFoA7
PSI Expands Support for Global Clinical Trials With First Office in Türkiye - PSI CRO
https://psi-cro.com
-
Deciding whether your clinical trial needs a data safety monitoring board can be difficult due to the lack of set guidelines to help provide direction and the complexity of setting them up and managing them once in place. Swipe through to look at some of our top things to consider when deciding to implement a DSMB, and read the full white paper at https://lnkd.in/eMPGaHWe
-
For drug developers in the burgeoning field of radiopharmaceuticals, the University of Missouri Research Reactor (MURR) is the essential first stop. PSI was proud to join the MURR team to discuss how Mizzou’s innovations are shaping the future of precision medicine. https://bit.ly/4cCcXZF
Pioneering Progress in Cancer Treatments [MURR Joint Publication] - PSI CRO
https://psi-cro.com
-
In our latest spotlight story, we dive into Bo's journey to discovering her passion for clinical research and her professional growth at PSI: https://lnkd.in/eGanfGxh #PSIProud #PSICareers
Team Member Spotlight: Insights from a CRA II
https://psi-cro.com
-
Connect with our team later this month in San Diego at the 3rd Targeted Radiopharmaceuticals Summit US! Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget and learn why more than 95% of PSI’s customers are repeat or referrals. https://bit.ly/3Wd17j4
-
-
Increasing diversity in clinical trials is a top priority for our industry, and the FDA has just released a draft guidance to assist sponsors in this critical goal. Learn what's included and how to start planning here. https://bit.ly/4cNrVw1
FDA Seeking Comment on New Draft Guidance on Diversity Action Plans - PSI CRO
https://psi-cro.com
-
A Data Monitoring Committee (DMC), also known as a Data and Safety Monitoring Board (DSMB), is a powerful mechanism for managing risks to trial participant safety and well-being and data validity and integrity. Learn about the most common challenges sponsors face with DMC setup and administration based on PSI's 20+ years of experience managing these committees. https://bit.ly/3VF3A4o
Top 4 Challenges in Data Monitoring Committee Management - PSI CRO
https://psi-cro.com
-
We are proud to have received recognition from our sponsors for the seventh year in a row in the CRO Leadership Awards. This honor helps us continue our ongoing mission to be the best clinical research organization in the world as measured by our employees, clients, investigative sites, and vendors. Read the full press release here: https://bit.ly/4bi0MAC